A protein found in bacteria and eukaryotic mitochondria which delivers aminoacyl-tRNA's to the A site of the ribosome. The aminoacyl-tRNA is first bound to a complex of elongation factor Tu containing a molecule of bound GTP. The resulting complex is then bound to the 70S initiation complex. Simultaneously the GTP is hydrolyzed and a Tu-GDP complex is released from the 70S ribosome. The Tu-GTP complex is regenerated from the Tu-GDP complex by the Ts elongation factor and GTP.
Peptide elongation factor 1 is a multisubunit protein that is responsible for the GTP-dependent binding of aminoacyl-tRNAs to eukaryotic ribosomes. The alpha subunit (EF-1alpha) binds aminoacyl-tRNA and transfers it to the ribosome in a process linked to GTP hydrolysis. The beta and delta subunits (EF-1beta, EF-1delta) are involved in exchanging GDP for GTP. The gamma subunit (EF-1gamma) is a structural component.
Protein factors uniquely required during the elongation phase of protein synthesis.
Factors that utilize energy from the hydrolysis of GTP to GDP for peptide chain elongation. EC 3.6.1.-.
A process of GENETIC TRANSLATION, when an amino acid is transferred from its cognate TRANSFER RNA to the lengthening chain of PEPTIDES.
Intermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase. They are key compounds in the genetic translation process.
Peptide Elongation Factor 2 catalyzes the translocation of peptidyl-tRNA from the A site to the P site of eukaryotic ribosomes by a process linked to the hydrolysis of GTP to GDP.
Peptide Elongation Factor G catalyzes the translocation of peptidyl-tRNA from the A to the P site of bacterial ribosomes by a process linked to hydrolysis of GTP to GDP.
A group of uridine ribonucleotides in which the phosphate residues of each uridine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety.
Pyridine derivatives with one or more keto groups on the ring.
A transfer RNA which is specific for carrying phenylalanine to sites on the ribosomes in preparation for protein synthesis.
A guanine nucleotide containing two phosphate groups esterified to the sugar moiety.
Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION.
Antibiotic obtained from a Streptomyces variant considered as possibly effective against Streptococcus pyogenes infections. It may promote growth in poultry.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
The production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation (TRANSLATION, GENETIC). There are other, non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
Transcription factors whose primary function is to regulate the rate in which RNA is transcribed.
The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS.
Guanine nucleotides are cyclic or linear molecules that consist of a guanine base, a pentose sugar (ribose in the cyclic form, deoxyribose in the linear form), and one or more phosphate groups, playing crucial roles in signal transduction, protein synthesis, and regulation of enzymatic activities.
A monomeric calcium-calmodulin-dependent protein kinase subtype that specifically phosphorylates PEPTIDE ELONGATION FACTOR 2. The enzyme lacks a phosphorylatable activation domain that can respond to CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE, however it is regulated by phosphorylation by PROTEIN KINASE A and through intramolecular autophosphorylation.
A species of gram-negative, aerobic, rod-shaped bacteria found in hot springs of neutral to alkaline pH, as well as in hot-water heaters.
The small RNA molecules, 73-80 nucleotides long, that function during translation (TRANSLATION, GENETIC) to align AMINO ACIDS at the RIBOSOMES in a sequence determined by the mRNA (RNA, MESSENGER). There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs (RNA, TRANSFER, AMINO ACYL), each carries a specific amino acid to the ribosome to add to the elongating peptide chains.
Gram-negative aerobic rods found in warm water (40-79 degrees C) such as hot springs, hot water tanks, and thermally polluted rivers.
An inhibitor of Serine Endopeptidases. Acts as alkylating agent and is known to interfere with the translation process.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
A group of transfer RNAs which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis.
A transcriptional elongation factor complex that is comprised of a heterodimer of CYCLIN-DEPENDENT KINASE 9 and one of several CYCLINS including TYPE T CYCLINS and cyclin K. It functions by phosphorylating the carboxy-terminal domain of RNA POLYMERASE II.
The rate dynamics in chemical or physical systems.
Proteins found in any species of bacterium.
A species of fresh-water, flagellated EUKARYOTES in the phylum EUGLENIDA.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE.
The conversion of uncharged TRANSFER RNA to AMINO ACYL TRNA.
The process of cleaving a chemical compound by the addition of a molecule of water.
Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits.
A transfer RNA which is specific for carrying alanine to sites on the ribosomes in preparation for protein synthesis.
A transfer RNA which is specific for carrying asparagine to sites on the ribosomes in preparation for protein synthesis.
Peptides whose amino and carboxy ends are linked together with a peptide bond forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS. Some of them are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL).
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
A transfer RNA which is specific for carrying threonine to sites on the ribosomes in preparation for protein synthesis.
A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.
Substances that reduce the growth or reproduction of BACTERIA.
Transcription factors that form transcription initiation complexes on DNA, bind to specific DNA-DIRECTED RNA POLYMERASES and are required to initiate transcription. Although their binding may be localized to distinct sequence and structural motifs within the DNA they are considered non-specific with regard to the specific gene being transcribed.
Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis.
The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape.
A transfer RNA which is specific for carrying aspartic acid to sites on the ribosomes in preparation for protein synthesis.
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis.
Guanosine 5'-diphosphate 2'(3')-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I.
A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE).
A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS.
Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.
The functional hereditary units of BACTERIA.
Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
A species of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family BACILLACEAE, found in soil, hot springs, Arctic waters, ocean sediments, and spoiled food products.
The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure.
A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of ADENYLYL CYCLASES.
A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement.
A collection of cloned peptides, or chemically synthesized peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide.
The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.
The level of protein structure in which combinations of secondary protein structures (alpha helices, beta sheets, loop regions, and motifs) pack together to form folded shapes called domains. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Small proteins usually consist of only one domain but larger proteins may contain a number of domains connected by segments of polypeptide chain which lack regular secondary structure.
A transfer RNA which is specific for carrying methionine to sites on the ribosomes. During initiation of protein synthesis, tRNA(f)Met in prokaryotic cells and tRNA(i)Met in eukaryotic cells binds to the start codon (CODON, INITIATOR).
Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.
An essential amino acid that is required for the production of HISTAMINE.
Proteins prepared by recombinant DNA technology.

Functional-structural analysis of threonine 25, a residue coordinating the nucleotide-bound magnesium in elongation factor Tu. (1/591)

Elongation factor (EF) Tu Thr-25 is a key residue binding the essential magnesium complexed to nucleotide. We have characterized mutations at this position to the related Ser and to Ala, which abolishes the bond to Mg2+, and a double mutation, H22Y/T25S. Nucleotide interaction was moderately destabilized in EF-Tu(T25S) but strongly in EF-Tu(T25A) and EF-Tu(H22Y/T25S). Binding Phe-tRNAPhe to poly(U).ribosome needed a higher magnesium concentration for the latter two mutants but was comparable at 10 mM MgCl2. Whereas EF-Tu(T25S) synthesized poly(Phe), as effectively as wild type, the rate was reduced to 50% for EF-Tu(H22Y/T25S) and was, surprisingly, still 10% for EF-Tu(T25A). In contrast, protection of Phe-tRNAPhe against spontaneous hydrolysis by the latter two mutants was very low. The intrinsic GTPase in EF-Tu(H22Y/T25S) and (T25A) was reduced, and the different responses to ribosomes and kirromycin suggest that stimulation by these two agents follows different mechanisms. Of the mutants, only EF-Tu(T25A) forms a more stable complex with EF-Ts than wild type. This implies that stabilization of the EF-Tu.EF-Ts complex is related to the inability to bind Mg2+, rather than to a decreased nucleotide affinity. These results are discussed in the light of the three-dimensional structure. They emphasize the importance of the Thr-25-Mg2+ bond, although its absence is compatible with protein synthesis and thus with an active overall conformation of EF-Tu.  (+info)

Dynamics and efficiency in vivo of UGA-directed selenocysteine insertion at the ribosome. (2/591)

The kinetics and efficiency of decoding of the UGA of a bacterial selenoprotein mRNA with selenocysteine has been studied in vivo. A gst-lacZ fusion, with the fdhF SECIS element ligated between the two fusion partners, gave an efficiency of read-through of 4-5%; overproduction of the selenocysteine insertion machinery increased it to 7-10%. This low efficiency is caused by termination at the UGA and not by translational barriers at the SECIS. When the selenocysteine UGA codon was replaced by UCA, and tRNASec with anticodon UGA was allowed to compete with seryl-tRNASer1 for this codon, selenocysteine was found in 7% of the protein produced. When a non-cognate SelB-tRNASec complex competed with EF-Tu for a sense codon, no effects were seen, whereas a non-cognate SelB-tRNASec competing with EF-Tu-mediated Su7-tRNA nonsense suppression of UGA interfered strongly with suppression. The induction kinetics of beta-galactosidase synthesis from fdhF'-'lacZ gene fusions in the absence or presence of SelB and/or the SECIS element, showed that there was a translational pause in the fusion containing the SECIS when SelB was present. The results show that decoding of UGA is an inefficient process and that using the third dimension of the mRNA to accommodate an additional amino acid is accompanied by considerable quantitative and kinetic costs.  (+info)

Identification of women with early breast cancer by analysis of p43-positive lymphocytes. (3/591)

Regular screening mammographies and increasing knowledge of high-risk groups have resulted in an improvement in the rate of detection of smaller malignant lesions. However, uncertain minimal mammographic features frequently require further costly and often uncomfortable investigation, including repeat radiological controls or surgical procedures, before cancerous lesions can be identified. Placental isoferritin (p43), a protein with immunosuppressive effects, has been detected on the surface of lymphocytes taken from peripheral blood in patients with breast cancer. In this study we evaluated the sensitivity and specificity of the expression of p43-positive lymphocytes as a marker in early stage breast cancer and also investigated its expression on T-cell subpopulations. The presence of p43-positive lymphocytes was investigated using the monoclonal antibody CM-H-9 and flow cytometry in 76 women with controversial, non-palpable mammographic findings who were undergoing surgical biopsy. Patients with early breast cancer (n = 48) had significantly higher p43-positive cell values (median 3.83%, range 0.98-19.4) than patients with benign lumps (n = 28, median 1.43%, range 0.17-3.7) or controls (n = 22, median 1.3%, range 0.4-1.87) (P < 0.0001). At a cut-off level of 2% p43-positive cells a sensitivity of 91.7% and a specificity of 89.3% for detection of breast cancer could be reached. While the median ratio of total CD4+/CD8+ cells was 2.6, a ratio of 1.3 was found for the p43-positive subpopulation (P < 0.001), thus indicating a significant link between p43 and CD8+ cells. The determination of p43-positive lymphocytes in peripheral blood could serve as an additional diagnostic tool in patients with controversial mammographic findings and could also reduce the need for cost-intensive and often uncomfortable management of these patients.  (+info)

Induced fit in initial selection and proofreading of aminoacyl-tRNA on the ribosome. (4/591)

The fidelity of aminoacyl-tRNA (aa-tRNA) selection by the bacterial ribosome is determined by initial selection before and proofreading after GTP hydrolysis by elongation factor Tu. Here we report the rate constants of A-site binding of a near-cognate aa-tRNA. The comparison with the data for cognate aa-tRNA reveals an additional, important contribution to aa-tRNA discrimination of conformational coupling by induced fit. It is found that two rearrangement steps that limit the chemical reactions of A-site binding, i.e. GTPase activation (preceding GTP hydrolysis) and A-site accommodation (preceding peptide bond formation), are substantially faster for cognate than for near-cognate aa-tRNA. This suggests an induced-fit mechanism of aa-tRNA discrimination on the ribosome that operates in both initial selection and proofreading. It is proposed that the cognate codon-anticodon interaction, more efficiently than the near-cognate one, induces a particular conformation of the decoding center of 16S rRNA, which in turn promotes GTPase activation and A-site accommodation of aa-tRNA, thereby accelerating the chemical steps. As kinetically favored incorporation of the correct substrate has also been suggested for DNA and RNA polymerases, the present findings indicate that induced fit may contribute to the fidelity of template-programed systems in general.  (+info)

Effects of domain exchanges between Escherichia coli and mammalian mitochondrial EF-Tu on interactions with guanine nucleotides, aminoacyl-tRNA and ribosomes. (5/591)

Escherichia coli elongation factor (EF-Tu) and the corresponding mammalian mitochondrial factor, EF-Tumt, show distinct differences in their affinities for guanine nucleotides and in their interactions with elongation factor Ts (EF-Ts) and mitochondrial tRNAs. To investigate the roles of the three domains of EF-Tu in these differences, six chimeric proteins were prepared in which the three domains were systematically switched. E. coli EF-Tu binds GDP much more tightly than EF-Tumt. This difference does not reside in domain I alone but is regulated by interactions with domains II and III. All the chimeric proteins formed ternary complexes with GTP and aminoacyl-tRNA although some had an increased or decreased activity in this assay. The activity of E. coli EF-Tu but not of EF-Tumt is stimulated by E. coli EF-Ts. The presence of any one of the domains of EF-Tumt in the prokaryotic factor reduced its interaction with E. coli EF-Ts 2-3-fold. In contrast, the presence of any of the three domains of E. coli EF-Tu in EF-Tumt allowed the mitochondrial factor to interact with bacterial EF-Ts. This observation indicates that even domain II which is not in contact with EF-Ts plays an important role in the nucleotide exchange reaction. EF-Tsmt interacts with all of the chimeras produced. However, with the exception of domain III exchanges, it inhibits the activities of the chimeras indicating that it could not be productively released to allow formation of the ternary complex. The unique ability of EF-Tumt to promote binding of mitochondrial Phe-tRNAPhe to the A-site of the ribosome resides in domains I and II. These studies indicate that the interactions of EF-Tu with its ligands is a complex process involving cross-talk between all three domains.  (+info)

Possible evolution of factors involved in protein biosynthesis. (6/591)

The elongation factors of protein biosynthesis are well preserved through out evolution. They catalyze the elongation phase of protein biosynthesis, where on the ribosome amino acids are added one at a time to a growing peptide according to the genetic information transcribed into mRNA. Elongation factor Tu (EF-Tu) provides the binding of aminoacylated tRNA to the ribosome and protects the aminoester bond against hydrolysis until a correct match between the codon on mRNA and the anticodon on tRNA can be achieved. Elongation factor G (EF-G) supports the translocation of tRNAs and of mRNA on the ribosome so that a new codon can be exposed for decoding. Both these factors are GTP binding proteins, and as such exist in an active form with GTP and an inactive form with GDP bound to the nucleotide binding domain. Elongation factor Ts (EF-Ts) will catalyze the exchange of nucleotide on EF-Tu. This review describes structural work on EF-Tu performed in our laboratory over the last eight years. The structural results provide a rather complete picture of the major structural forms of EF-Tu, including the so called ternary complex of aa-tRNA:EF-Tu:GTP. The structural comparison of this ternary complex with the structure of EF-G:GDP displays an unexpected macromolecular mimicry, where three domains of EF-G mimick the shape of the tRNA in the ternary complex. This observation has initiated much speculation on the evolution of all factors involved in protein synthesis, as well as on the details of the ribosomal function in one part of elongation.  (+info)

NSF N-terminal domain crystal structure: models of NSF function. (7/591)

N-ethylmaleimide-sensitive factor (NSF) is a hexameric ATPase essential for eukaryotic vesicle fusion. Along with SNAP proteins, it disassembles cis-SNARE complexes upon ATP hydrolysis, preparing SNAREs for trans complex formation. We have determined the crystal structure of the N-terminal domain of NSF (N) to 1.9 A resolution. N contains two subdomains which form a groove that is a likely SNAP interaction site. Unexpectedly, both N subdomains are structurally similar to domains in EF-Tu. Based on this similarity, we propose a model for a large conformational change in NSF that drives SNARE complex disassembly.  (+info)

Predicting conformational switches in proteins. (8/591)

We describe a new computational technique to predict conformationally switching elements in proteins from their amino acid sequences. The method, called ASP (Ambivalent Structure Predictor), analyzes results from a secondary structure prediction algorithm to identify regions of conformational ambivalence. ASP identifies ambivalent regions in 16 test protein sequences for which function involves substantial backbone rearrangements. In the test set, all sites previously described as conformational switches are correctly predicted to be structurally ambivalent regions. No such regions are predicted in three negative control protein sequences. ASP may be useful as a guide for experimental studies on protein function and motion in the absence of detailed three-dimensional structural data.  (+info)

Peptide Elongation Factor Tu, also known as EF-Tu or Tuf, is a protein involved in the process of protein synthesis in prokaryotic cells. It plays a crucial role in the elongation phase of translation, where it facilitates the addition of amino acids to the growing polypeptide chain during protein synthesis.

EF-Tu functions as a binding protein for aminoacyl-tRNA (transfer RNA) complexes. In this role, EF-Tu forms a ternary complex with GTP (guanosine triphosphate) and an aminoacyl-tRNA, which then binds to the A (acceptor) site of the small ribosomal subunit. Once aligned, the GTP in the EF-Tu-tRNA complex is hydrolyzed to GDP (guanosine diphosphate), causing a conformational change that releases the aminoacyl-tRNA into the A site for peptide bond formation.

After releasing the tRNA, EF-Tu recharges with another GTP molecule and is ready to form another ternary complex, thus continuing its role in the elongation of protein synthesis. The recycling of EF-Tu between GDP and GTP forms is facilitated by another elongation factor, EF-Ts (or Tsf).

In summary, Peptide Elongation Factor Tu (EF-Tu) is a vital protein in prokaryotic cells that binds to aminoacyl-tRNA and GTP, forming a ternary complex. This complex delivers the aminoacyl-tRNA to the ribosome for peptide bond formation during protein synthesis elongation.

Peptide Elongation Factor 1 (PEF1) is not a commonly used medical term, but it is a term used in biochemistry and molecular biology. Here's the definition:

Peptide Elongation Factor 1 (also known as EF-Tu in prokaryotes or EFT1A/EFT1B in eukaryotes) is a protein involved in the elongation phase of protein synthesis, specifically during translation. It plays a crucial role in delivering aminoacyl-tRNAs to the ribosome, enabling the addition of new amino acids to the growing polypeptide chain.

In eukaryotic cells, EF1A and EF1B (also known as EF-Ts) form a complex that helps facilitate the binding of aminoacyl-tRNAs to the ribosome. In prokaryotic cells, EF-Tu forms a complex with GTP and aminoacyl-tRNA, which then binds to the ribosome. Once bound, GTP is hydrolyzed to GDP, causing a conformational change that releases the aminoacyl-tRNA into the acceptor site of the ribosome, allowing for peptide bond formation. The EF-Tu/GDP complex then dissociates from the ribosome and is recycled by another protein called EF-G (EF-G in prokaryotes or EFL1 in eukaryotes).

Therefore, Peptide Elongation Factor 1 plays a critical role in ensuring that the correct amino acids are added to the growing peptide chain during protein synthesis.

Peptide elongation factors are a group of proteins that play a crucial role in the process of protein synthesis in cells, specifically during the elongation stage of translation. They assist in the addition of amino acids to the growing polypeptide chain by facilitating the binding of aminoacyl-tRNAs (transfer RNAs with attached amino acids) to the ribosome, where protein synthesis occurs.

In prokaryotic cells, there are two main peptide elongation factors: EF-Tu and EF-G. EF-Tu forms a complex with aminoacyl-tRNA and delivers it to the ribosome's acceptor site (A-site), where the incoming amino acid is matched with the corresponding codon on the mRNA. Once the correct match is made, GTP hydrolysis occurs, releasing EF-Tu from the complex, allowing for peptide bond formation between the new amino acid and the growing polypeptide chain.

EF-G then enters the scene to facilitate translocation, the movement of the ribosome along the mRNA, which shifts the newly formed peptidyl-tRNA from the A-site to the P-site (peptidyl-tRNA site) and makes room for another aminoacyl-tRNA in the A-site. This process continues until protein synthesis is complete.

In eukaryotic cells, the equivalent proteins are called EF1α, EF1β, EF1γ, and EF2 (also known as eEF1A, eEF1B, eEF1G, and eEF2). The overall function remains similar to that in prokaryotes, but the specific mechanisms and protein names differ.

GTP (Guanosine Triphosphate) Phosphohydrolase-Linked Elongation Factors are a group of proteins that play a crucial role in protein synthesis, specifically in the elongation phase of translation. These factors use the energy released from GTP hydrolysis to facilitate various steps in the addition of amino acids to the growing polypeptide chain during protein synthesis.

In prokaryotic cells, there are two main GTP Phosphohydrolase-Linked Elongation Factors: EF-Tu (Elongation Factor Thermos unstable) and EF-G (Elongation Factor G).

EF-Tu forms a complex with aminoacyl-tRNA and GTP, which then binds to the ribosome. Upon correct codon-anticodon recognition, GTP is hydrolyzed to GDP, releasing EF-Tu from the ribosome and allowing for the addition of the amino acid to the polypeptide chain.

EF-G, on the other hand, facilitates the translocation of the peptidyl-tRNA from the A site to the P site of the ribosome after peptide bond formation, using GTP hydrolysis as an energy source. This movement makes room for a new aminoacyl-tRNA to bind and continue the elongation process.

In eukaryotic cells, there are functionally equivalent factors called EF1A (eEF1A) and EF2 (eEF2), which perform similar roles in protein synthesis.

Translational peptide chain elongation is the process during protein synthesis where activated amino acids are added to the growing peptide chain in a sequence determined by the genetic code present in messenger RNA (mRNA). This process involves several steps:

1. Recognition of the start codon on the mRNA by the small ribosomal subunit, which binds to the mRNA and brings an initiator tRNA with a methionine or formylmethionine amino acid attached into the P site (peptidyl site) of the ribosome.
2. The large ribosomal subunit then joins the small subunit, forming a complete ribosome complex.
3. An incoming charged tRNA with an appropriate amino acid, complementary to the next codon on the mRNA, binds to the A site (aminoacyl site) of the ribosome.
4. Peptidyl transferase, a catalytic domain within the large ribosomal subunit, facilitates the formation of a peptide bond between the amino acids attached to the tRNAs in the P and A sites. The methionine or formylmethionine initiator amino acid is now covalently linked to the second amino acid via this peptide bond.
5. Translocation occurs, moving the tRNA with the growing peptide chain from the P site to the E site (exit site) and shifting the mRNA by one codon relative to the ribosome. The uncharged tRNA is then released from the E site.
6. The next charged tRNA carrying an appropriate amino acid binds to the A site, and the process repeats until a stop codon is reached on the mRNA.
7. Upon encountering a stop codon, release factors recognize it and facilitate the release of the completed polypeptide chain from the final tRNA in the P site. The ribosome then dissociates from the mRNA, allowing for further translational events to occur.

Translational peptide chain elongation is a crucial step in protein synthesis and requires precise coordination between various components of the translation machinery, including ribosomes, tRNAs, amino acids, and numerous accessory proteins.

Transfer RNA (tRNA) is a type of RNA molecule that plays a crucial role in protein synthesis. It serves as the adaptor molecule that translates the genetic code present in messenger RNA (mRNA) into the corresponding amino acids, which are then linked together to form a polypeptide chain during protein synthesis.

Aminoacyl tRNA is a specific type of tRNA molecule that has been charged or activated with an amino acid. This process is called aminoacylation and is carried out by enzymes called aminoacyl-tRNA synthetases. Each synthetase specifically recognizes and attaches a particular amino acid to its corresponding tRNA, ensuring the fidelity of protein synthesis. Once an amino acid is attached to a tRNA, it forms an aminoacyl-tRNA complex, which can then participate in translation and contribute to the formation of a new protein.

Peptide Elongation Factor 2 (PEF2), also known as Elongation Factor-G (EF-G) in prokaryotes or Translation Elongation Factor 2 (TEF2) in eukaryotes, is a vital protein involved in the elongation phase of protein synthesis, specifically during translation. It facilitates the translocation of peptidyl-tRNA from the A-site to the P-site of the ribosome, thereby enabling the addition of new amino acids to the growing polypeptide chain.

During this process, PEF2/EF-G/TEF2 binds to the ribosome and utilizes the energy from GTP hydrolysis to induce a conformational change in the ribosome, leading to the translocation of peptidyl-tRNA and mRNA. After completing the translocation step, PEF2/EF-G/TEF2 is released from the ribosome and can be reused in subsequent elongation cycles.

In summary, Peptide Elongation Factor 2 (PEF2) is a crucial player in protein synthesis that facilitates the movement of peptidyl-tRNA within the ribosome during translation, allowing for the continuous addition of amino acids to the nascent polypeptide chain.

Peptide Elongation Factor G is a term used in the field of molecular biology, specifically in the process of protein synthesis. It is a bacterial enzyme that plays a crucial role in the elongation stage of translation, which is the process by which genetic information encoded in messenger RNA (mRNA) is converted into a polypeptide chain or protein.

More specifically, Peptide Elongation Factor G (also known as EF-G or Translocase) is responsible for the translocation step during translation. After each amino acid is added to the growing peptide chain, the mRNA and tRNAs must move relative to the ribosome so that the next codon in the mRNA can be read. EF-G facilitates this movement by using energy from GTP hydrolysis to cause a conformational change in the ribosome, resulting in the translocation of the mRNA and tRNAs by one codon.

In summary, Peptide Elongation Factor G is a bacterial enzyme that plays an essential role in the elongation stage of protein synthesis by facilitating the movement of mRNA and tRNAs relative to the ribosome during translation.

I'm sorry for any confusion, but "Poly U" is not a recognized medical term or abbreviation in the English language. It could potentially refer to Polytechnic University or Hong Kong Polytechnic University, but it does not have a specific medical connotation. If you have more context or information, I'd be happy to help further!

Guanosine triphosphate (GTP) is a nucleotide that plays a crucial role in various cellular processes, such as protein synthesis, signal transduction, and regulation of enzymatic activities. It serves as an energy currency, similar to adenosine triphosphate (ATP), and undergoes hydrolysis to guanosine diphosphate (GDP) or guanosine monophosphate (GMP) to release energy required for these processes. GTP is also a precursor for the synthesis of other essential molecules, including RNA and certain signaling proteins. Additionally, it acts as a molecular switch in many intracellular signaling pathways by binding and activating specific GTPase proteins.

Pyridones are a class of organic compounds that contain a pyridone ring, which is a heterocyclic ring consisting of a six-membered ring with five carbon atoms and one nitrogen atom, with one oxygen atom attached to the nitrogen atom by a double bond. Pyridones can be found in various natural sources, including plants and microorganisms, and they also have important applications in the pharmaceutical industry as building blocks for drug design and synthesis. Some drugs that contain pyridone rings include antihistamines, anti-inflammatory agents, and antiviral agents.

Transfer RNA (tRNA) is a type of RNA molecule that helps translate genetic information from messenger RNA (mRNA) into proteins. Each tRNA carries a specific amino acid to the growing polypeptide chain during protein synthesis, based on the anticodon sequence in its variable loop region that recognizes and binds to a complementary codon sequence in the mRNA.

Phenylalanine (Phe) is one of the twenty standard amino acids found in proteins. It has a hydrophobic side chain, which means it tends to repel water and interact with other non-polar molecules. In tRNA, phenylalanine is attached to a specific tRNA molecule known as tRNAPhe. This tRNA recognizes the mRNA codons UUC and UUU, which specify phenylalanine during protein synthesis.

Guanosine diphosphate (GDP) is a nucleotide that consists of a guanine base, a sugar molecule called ribose, and two phosphate groups. It is an ester of pyrophosphoric acid with the hydroxy group of the ribose sugar at the 5' position. GDP plays a crucial role as a secondary messenger in intracellular signaling pathways and also serves as an important intermediate in the synthesis of various biomolecules, such as proteins and polysaccharides.

In cells, GDP is formed from the hydrolysis of guanosine triphosphate (GTP) by enzymes called GTPases, which convert GTP to GDP and release energy that can be used to power various cellular processes. The conversion of GDP back to GTP can be facilitated by nucleotide diphosphate kinases, allowing for the recycling of these nucleotides within the cell.

It is important to note that while guanosine diphosphate has a significant role in biochemical processes, it is not typically associated with medical conditions or diseases directly. However, understanding its function and regulation can provide valuable insights into various physiological and pathophysiological mechanisms.

Ribosomes are complex macromolecular structures composed of ribonucleic acid (RNA) and proteins that play a crucial role in protein synthesis within cells. They serve as the site for translation, where messenger RNA (mRNA) is translated into a specific sequence of amino acids to create a polypeptide chain, which eventually folds into a functional protein.

Ribosomes consist of two subunits: a smaller subunit and a larger subunit. These subunits are composed of ribosomal RNA (rRNA) molecules and proteins. In eukaryotic cells, the smaller subunit is denoted as the 40S subunit, while the larger subunit is referred to as the 60S subunit. In prokaryotic cells, these subunits are named the 30S and 50S subunits, respectively. The ribosome's overall structure resembles a "doughnut" or a "cotton reel," with grooves and binding sites for various factors involved in protein synthesis.

Ribosomes can be found floating freely within the cytoplasm of cells or attached to the endoplasmic reticulum (ER) membrane, forming part of the rough ER. Membrane-bound ribosomes are responsible for synthesizing proteins that will be transported across the ER and ultimately secreted from the cell or inserted into the membrane. In contrast, cytoplasmic ribosomes synthesize proteins destined for use within the cytoplasm or organelles.

In summary, ribosomes are essential components of cells that facilitate protein synthesis by translating mRNA into functional polypeptide chains. They can be found in various cellular locations and exist as either free-floating entities or membrane-bound structures.

I apologize for the confusion, but "Aurodox" is not a medical term or a medication that is recognized in medical literature or by major healthcare organizations. It's possible that you may have misspelled the name or it could be a term used in a specific context, such as a research project or a product in development. If you have more information about where you encountered this term, I might be able to provide a more accurate response.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Peptide biosynthesis is the process by which cells synthesize peptides, short chains of amino acids. This process is mediated by enzymes called peptide synthetases, which catalyze the formation of peptide bonds between individual amino acids to create a longer chain. Peptide biosynthesis typically occurs through one of two pathways: ribosomal or non-ribosomal.

Ribosomal peptide biosynthesis involves the use of the cell's translational machinery, including the ribosome and transfer RNAs (tRNAs), to synthesize peptides from a messenger RNA (mRNA) template. This process is highly regulated and typically results in the production of small, linear peptides that are further modified by enzymes to create bioactive molecules such as hormones or neurotransmitters.

Non-ribosomal peptide biosynthesis (NRPS), on the other hand, is a more complex process that involves large multifunctional enzyme complexes called non-ribosomal peptide synthetases (NRPSs). These enzymes are capable of synthesizing a wide variety of structurally diverse peptides, including cyclic and branched peptides, as well as those containing non-proteinogenic amino acids. NRPSs typically consist of multiple modules, each responsible for adding a single amino acid to the growing peptide chain. The modular nature of NRPS systems allows for great diversity in the types of peptides that can be synthesized, making them important sources of bioactive molecules with potential therapeutic applications.

Peptides are short chains of amino acid residues linked by covalent bonds, known as peptide bonds. They are formed when two or more amino acids are joined together through a condensation reaction, which results in the elimination of a water molecule and the formation of an amide bond between the carboxyl group of one amino acid and the amino group of another.

Peptides can vary in length from two to about fifty amino acids, and they are often classified based on their size. For example, dipeptides contain two amino acids, tripeptides contain three, and so on. Oligopeptides typically contain up to ten amino acids, while polypeptides can contain dozens or even hundreds of amino acids.

Peptides play many important roles in the body, including serving as hormones, neurotransmitters, enzymes, and antibiotics. They are also used in medical research and therapeutic applications, such as drug delivery and tissue engineering.

Transcriptional elongation factors are a type of protein involved in the process of transcription, which is the synthesis of an RNA molecule from a DNA template. Specifically, transcriptional elongation factors play a role in the elongation phase of transcription, which is the stage at which the RNA polymerase enzyme moves along the DNA template and adds nucleotides to the growing RNA chain.

These factors help to regulate the speed and processivity of RNA polymerase, allowing for the accurate and efficient production of RNA molecules. They can also play a role in the coordination of transcription with other cellular processes, such as mRNA processing and translation. Some examples of transcriptional elongation factors include the TFIIS complex, SII complex, and elongin. Defects in these factors can lead to abnormalities in gene expression and have been implicated in various diseases, including cancer.

Protein biosynthesis is the process by which cells generate new proteins. It involves two major steps: transcription and translation. Transcription is the process of creating a complementary RNA copy of a sequence of DNA. This RNA copy, or messenger RNA (mRNA), carries the genetic information to the site of protein synthesis, the ribosome. During translation, the mRNA is read by transfer RNA (tRNA) molecules, which bring specific amino acids to the ribosome based on the sequence of nucleotides in the mRNA. The ribosome then links these amino acids together in the correct order to form a polypeptide chain, which may then fold into a functional protein. Protein biosynthesis is essential for the growth and maintenance of all living organisms.

Guanine nucleotides are molecules that play a crucial role in intracellular signaling, cellular regulation, and various biological processes within cells. They consist of a guanine base, a sugar (ribose or deoxyribose), and one or more phosphate groups. The most common guanine nucleotides are GDP (guanosine diphosphate) and GTP (guanosine triphosphate).

GTP is hydrolyzed to GDP and inorganic phosphate by certain enzymes called GTPases, releasing energy that drives various cellular functions such as protein synthesis, signal transduction, vesicle transport, and cell division. On the other hand, GDP can be rephosphorylated back to GTP by nucleotide diphosphate kinases, allowing for the recycling of these molecules within the cell.

In addition to their role in signaling and regulation, guanine nucleotides also serve as building blocks for RNA (ribonucleic acid) synthesis during transcription, where they pair with cytosine nucleotides via hydrogen bonds to form base pairs in the resulting RNA molecule.

Elongation Factor 2 Kinase (eEF2K) is a type of protein kinase that phosphorylates and inactivates elongation factor 2 (eEF2), a crucial player in protein synthesis. Specifically, eEF2 is responsible for translocating the ribosome along the mRNA during translation, and its phosphorylation by eEF2K leads to a decrease in protein synthesis rates.

eEF2K is activated under conditions of cellular stress, such as nutrient deprivation or hypoxia, and functions to conserve energy by reducing protein synthesis. The kinase is also involved in various cellular processes, including autophagy, apoptosis, and cancer progression. Inhibition of eEF2K has been proposed as a potential therapeutic strategy for treating various diseases, including neurodegenerative disorders and cancer.

'Thermus thermophilus' is not a medical term, but a scientific name for a species of bacteria. It is commonly used in molecular biology and genetics research. Here is the biological definition:

'Thermus thermophilus' is a gram-negative, rod-shaped, thermophilic bacterium found in hot springs and other high-temperature environments. Its optimum growth temperature ranges from 65 to 70°C (149-158°F), with some strains able to grow at temperatures as high as 85°C (185°F). The bacterium's DNA polymerase enzyme, Taq polymerase, is widely used in the Polymerase Chain Reaction (PCR) technique for amplifying and analyzing DNA. 'Thermus thermophilus' has a single circular chromosome and can also have one or more plasmids. Its genome has been fully sequenced, making it an important model organism for studying extremophiles and their adaptations to harsh environments.

Transfer RNA (tRNA) is a type of RNA molecule that plays a crucial role in protein synthesis, the process by which cells create proteins. In protein synthesis, tRNAs serve as adaptors, translating the genetic code present in messenger RNA (mRNA) into the corresponding amino acids required to build a protein.

Each tRNA molecule has a distinct structure, consisting of approximately 70-90 nucleotides arranged in a cloverleaf shape with several loops and stems. The most important feature of a tRNA is its anticodon, a sequence of three nucleotides located in one of the loops. This anticodon base-pairs with a complementary codon on the mRNA during translation, ensuring that the correct amino acid is added to the growing polypeptide chain.

Before tRNAs can participate in protein synthesis, they must be charged with their specific amino acids through an enzymatic process involving aminoacyl-tRNA synthetases. These enzymes recognize and bind to both the tRNA and its corresponding amino acid, forming a covalent bond between them. Once charged, the aminoacyl-tRNA complex is ready to engage in translation and contribute to protein formation.

In summary, transfer RNA (tRNA) is a small RNA molecule that facilitates protein synthesis by translating genetic information from messenger RNA into specific amino acids, ultimately leading to the creation of functional proteins within cells.

"Thermus" is not a medical term, but rather a genus of bacteria that are capable of growing in extreme temperatures. These bacteria are named after the Greek word "therme," which means heat. They are commonly found in hot springs and deep-sea hydrothermal vents, where the temperature can reach up to 70°C (158°F).

Some species of Thermus have been found to produce enzymes that remain active at high temperatures, making them useful in various industrial applications such as molecular biology and DNA amplification techniques like polymerase chain reaction (PCR). However, Thermus itself is not a medical term or concept.

Tosylphenylalanyl Chloromethyl Ketone (TPCK) is not a medical term per se, but it is a chemical compound that has been used in medical research. Here's the definition of this compound:

Tosylphenylalanyl Chloromethyl Ketone is a synthetic chemical compound with the formula C14H12ClNO3S. It is a white crystalline powder that is soluble in organic solvents and has a molecular weight of 307.75 g/mol.

TPCK is an irreversible inhibitor of serine proteases, which are enzymes that cut other proteins at specific amino acid sequences. TPCK works by reacting with the active site of these enzymes and forming a covalent bond, thereby blocking their activity. It has been used in research to study the role of serine proteases in various biological processes, including inflammation, blood coagulation, and cancer.

It is important to note that TPCK is highly toxic and should be handled with appropriate safety precautions, including the use of personal protective equipment (PPE) such as gloves and lab coats, and proper disposal in accordance with local regulations.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Protein binding, in the context of medical and biological sciences, refers to the interaction between a protein and another molecule (known as the ligand) that results in a stable complex. This process is often reversible and can be influenced by various factors such as pH, temperature, and concentration of the involved molecules.

In clinical chemistry, protein binding is particularly important when it comes to drugs, as many of them bind to proteins (especially albumin) in the bloodstream. The degree of protein binding can affect a drug's distribution, metabolism, and excretion, which in turn influence its therapeutic effectiveness and potential side effects.

Protein-bound drugs may be less available for interaction with their target tissues, as only the unbound or "free" fraction of the drug is active. Therefore, understanding protein binding can help optimize dosing regimens and minimize adverse reactions.

Transfer RNA (tRNA) are small RNA molecules that play a crucial role in protein synthesis. They are responsible for translating the genetic code contained within messenger RNA (mRNA) into the specific sequence of amino acids during protein synthesis.

Amino acid-specific tRNAs are specialized tRNAs that recognize and bind to specific amino acids. Each tRNA has an anticodon region that can base-pair with a complementary codon on the mRNA, which determines the specific amino acid that will be added to the growing polypeptide chain during protein synthesis.

Therefore, a more detailed medical definition of "RNA, Transfer, Amino Acid-Specific" would be:

A type of transfer RNA (tRNA) molecule that is specific to a particular amino acid and plays a role in translating the genetic code contained within messenger RNA (mRNA) into the specific sequence of amino acids during protein synthesis. The anticodon region of an amino acid-specific tRNA base-pairs with a complementary codon on the mRNA, which determines the specific amino acid that will be added to the growing polypeptide chain during protein synthesis.

Positive Transcriptional Elongation Factor B (P-TEFb) is a crucial protein complex in the process of transcription, which is the first step in gene expression. The main function of P-TEFb is to help RNA polymerase II, the enzyme responsible for transcribing DNA into RNA, to continue and complete the transcription of genes.

P-TEFb is composed of two subunits: cyclin T (CYCT) and CDK9 (cyclin-dependent kinase 9). The complex acts by phosphorylating several proteins that associate with RNA polymerase II, including the negative elongation factors NELF and DSIF. This phosphorylation converts NELF from a repressor to an activator of transcription elongation and relieves DSIF-mediated pausing of RNA polymerase II, allowing it to transcribe genes efficiently.

P-TEFb plays a significant role in regulating the expression of numerous genes, including those involved in cell growth, differentiation, and survival. Its dysregulation has been implicated in several diseases, such as cancer and HIV infection. In cancer, P-TEFb can contribute to oncogene activation and tumor progression, while in HIV, it is required for the transcription of viral genes during the early and late stages of infection.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

'Euglena gracilis' is a species of unicellular flagellate belonging to the genus Euglena. It is a common freshwater organism, characterized by its elongated, flexible shape and distinct eyespot that allows it to move towards light sources. 'Euglena gracilis' contains chloroplasts for photosynthesis but can also consume other organic matter through phagocytosis, making it a facultative autotroph. It is often used as a model organism in scientific research due to its unique combination of features from both plant and animal kingdoms.

A peptide fragment is a short chain of amino acids that is derived from a larger peptide or protein through various biological or chemical processes. These fragments can result from the natural breakdown of proteins in the body during regular physiological processes, such as digestion, or they can be produced experimentally in a laboratory setting for research or therapeutic purposes.

Peptide fragments are often used in research to map the structure and function of larger peptides and proteins, as well as to study their interactions with other molecules. In some cases, peptide fragments may also have biological activity of their own and can be developed into drugs or diagnostic tools. For example, certain peptide fragments derived from hormones or neurotransmitters may bind to receptors in the body and mimic or block the effects of the full-length molecule.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Molecular models are three-dimensional representations of molecular structures that are used in the field of molecular biology and chemistry to visualize and understand the spatial arrangement of atoms and bonds within a molecule. These models can be physical or computer-generated and allow researchers to study the shape, size, and behavior of molecules, which is crucial for understanding their function and interactions with other molecules.

Physical molecular models are often made up of balls (representing atoms) connected by rods or sticks (representing bonds). These models can be constructed manually using materials such as plastic or wooden balls and rods, or they can be created using 3D printing technology.

Computer-generated molecular models, on the other hand, are created using specialized software that allows researchers to visualize and manipulate molecular structures in three dimensions. These models can be used to simulate molecular interactions, predict molecular behavior, and design new drugs or chemicals with specific properties. Overall, molecular models play a critical role in advancing our understanding of molecular structures and their functions.

Protein conformation refers to the specific three-dimensional shape that a protein molecule assumes due to the spatial arrangement of its constituent amino acid residues and their associated chemical groups. This complex structure is determined by several factors, including covalent bonds (disulfide bridges), hydrogen bonds, van der Waals forces, and ionic bonds, which help stabilize the protein's unique conformation.

Protein conformations can be broadly classified into two categories: primary, secondary, tertiary, and quaternary structures. The primary structure represents the linear sequence of amino acids in a polypeptide chain. The secondary structure arises from local interactions between adjacent amino acid residues, leading to the formation of recurring motifs such as α-helices and β-sheets. Tertiary structure refers to the overall three-dimensional folding pattern of a single polypeptide chain, while quaternary structure describes the spatial arrangement of multiple folded polypeptide chains (subunits) that interact to form a functional protein complex.

Understanding protein conformation is crucial for elucidating protein function, as the specific three-dimensional shape of a protein directly influences its ability to interact with other molecules, such as ligands, nucleic acids, or other proteins. Any alterations in protein conformation due to genetic mutations, environmental factors, or chemical modifications can lead to loss of function, misfolding, aggregation, and disease states like neurodegenerative disorders and cancer.

Phenylalanine is an essential amino acid, meaning it cannot be produced by the human body and must be obtained through diet or supplementation. It's one of the building blocks of proteins and is necessary for the production of various molecules in the body, such as neurotransmitters (chemical messengers in the brain).

Phenylalanine has two forms: L-phenylalanine and D-phenylalanine. L-phenylalanine is the form found in proteins and is used by the body for protein synthesis, while D-phenylalanine has limited use in humans and is not involved in protein synthesis.

Individuals with a rare genetic disorder called phenylketonuria (PKU) must follow a low-phenylalanine diet or take special medical foods because they are unable to metabolize phenylalanine properly, leading to its buildup in the body and potential neurological damage.

Transfer RNA (tRNA) aminoacylation is the process by which an amino acid is chemically linked to a specific tRNA molecule through an ester bond. This reaction is catalyzed by an enzyme called aminoacyl-tRNA synthetase, which plays a crucial role in protein synthesis. Each type of tRNA corresponds to a particular amino acid, and the correct pairing between them ensures that the genetic code carried by messenger RNA (mRNA) is accurately translated into the corresponding amino acid sequence during protein synthesis. This precise matching of tRNAs with their respective amino acids is essential for maintaining the fidelity of the translation process and ultimately, for the proper functioning of proteins in living organisms.

Hydrolysis is a chemical process, not a medical one. However, it is relevant to medicine and biology.

Hydrolysis is the breakdown of a chemical compound due to its reaction with water, often resulting in the formation of two or more simpler compounds. In the context of physiology and medicine, hydrolysis is a crucial process in various biological reactions, such as the digestion of food molecules like proteins, carbohydrates, and fats. Enzymes called hydrolases catalyze these hydrolysis reactions to speed up the breakdown process in the body.

Ribosomal proteins are a type of protein that play a crucial role in the structure and function of ribosomes, which are complex molecular machines found within all living cells. Ribosomes are responsible for translating messenger RNA (mRNA) into proteins during the process of protein synthesis.

Ribosomal proteins can be divided into two categories based on their location within the ribosome:

1. Large ribosomal subunit proteins: These proteins are associated with the larger of the two subunits of the ribosome, which is responsible for catalyzing peptide bond formation during protein synthesis.
2. Small ribosomal subunit proteins: These proteins are associated with the smaller of the two subunits of the ribosome, which is responsible for binding to the mRNA and decoding the genetic information it contains.

Ribosomal proteins have a variety of functions, including helping to stabilize the structure of the ribosome, assisting in the binding of substrates and cofactors necessary for protein synthesis, and regulating the activity of the ribosome. Mutations in ribosomal proteins can lead to a variety of human diseases, including developmental disorders, neurological conditions, and cancer.

'RNA, Transfer, Ala' refers to a specific type of transfer RNA (tRNA) molecule that is involved in protein synthesis. In molecular biology, the term 'RNA' stands for ribonucleic acid, which is a nucleic acid present in the cells of all living organisms. Transfer RNAs are a type of RNA that help translate genetic information from messenger RNA (mRNA) into proteins during the process of protein synthesis or translation.

'Transfer, Ala' more specifically refers to a transfer RNA molecule that carries the amino acid alanine (Ala) to the ribosome during protein synthesis. Each tRNA has a specific anticodon sequence that can base-pair with a complementary codon sequence in the mRNA, and it also carries a specific amino acid that corresponds to that codon. In this case, the anticodon on the 'Transfer, Ala' tRNA molecule is capable of base-pairing with any one of the three codons (GCU, GCC, GCA, or GCG) that specify alanine in the genetic code.

Therefore, 'RNA, Transfer, Ala' can be defined as a type of transfer RNA molecule that carries and delivers the amino acid alanine to the growing polypeptide chain during protein synthesis.

Transfer RNA (tRNA) that carries asparagine (Asn) is a type of RNA molecule that plays a crucial role in protein synthesis. Specifically, tRNAs are responsible for delivering the appropriate amino acids to the ribosome during translation, the process by which genetic information encoded in messenger RNA (mRNA) is translated into proteins.

In the case of tRNA-Asn, this RNA molecule carries the amino acid asparagine, which is one of the 20 standard amino acids used to build proteins. The tRNA-Asn molecule recognizes a specific codon (a sequence of three nucleotides) in the mRNA that corresponds to asparagine, and then brings the appropriate amino acid to the ribosome to be incorporated into the growing polypeptide chain.

The correct pairing of tRNAs with their corresponding codons is facilitated by anticodon loops present on the tRNA molecules, which contain complementary sequences to the codons in the mRNA. In the case of tRNA-Asn, the anticodon loop contains the sequence UGU, which is complementary to the asparagine codons AAU and AAC in the mRNA.

Overall, tRNAs like tRNA-Asn are essential for the accurate and efficient synthesis of proteins in all living organisms.

Cyclic peptides are a type of peptides in which the N-terminus and C-terminus of the peptide chain are linked to form a circular structure. This is in contrast to linear peptides, which have a straight peptide backbone with a free N-terminus and C-terminus. The cyclization of peptides can occur through various mechanisms, including the formation of an amide bond between the N-terminal amino group and the C-terminal carboxylic acid group (head-to-tail cyclization), or through the formation of a bond between side chain functional groups.

Cyclic peptides have unique structural and chemical properties that make them valuable in medical and therapeutic applications. For example, they are more resistant to degradation by enzymes compared to linear peptides, which can increase their stability and half-life in the body. Additionally, the cyclic structure allows for greater conformational rigidity, which can enhance their binding affinity and specificity to target molecules.

Cyclic peptides have been explored as potential therapeutics for a variety of diseases, including cancer, infectious diseases, and neurological disorders. They have also been used as tools in basic research to study protein-protein interactions and cell signaling pathways.

A Structure-Activity Relationship (SAR) in the context of medicinal chemistry and pharmacology refers to the relationship between the chemical structure of a drug or molecule and its biological activity or effect on a target protein, cell, or organism. SAR studies aim to identify patterns and correlations between structural features of a compound and its ability to interact with a specific biological target, leading to a desired therapeutic response or undesired side effects.

By analyzing the SAR, researchers can optimize the chemical structure of lead compounds to enhance their potency, selectivity, safety, and pharmacokinetic properties, ultimately guiding the design and development of novel drugs with improved efficacy and reduced toxicity.

Transfer RNA (tRNA) is a type of RNA molecule that plays a crucial role in protein synthesis in the cell. It carries amino acids to the ribosome, where they are joined together in a specific sequence to form a polypeptide chain, which ultimately becomes a protein.

Each tRNA molecule has a unique structure and is responsible for carrying a specific amino acid. The genetic information that specifies which amino acid a particular tRNA carries is encoded in the form of a three-nucleotide sequence called an anticodon, which is located on one end of the tRNA molecule.

Threonine (Thr) is one of the twenty standard amino acids found in proteins. It is encoded by the codons ACU, ACA, ACC, and ACG in the genetic code. Therefore, a tRNA molecule with an anticodon complementary to any of these codons will carry threonine during protein synthesis.

So, to provide a medical definition of 'RNA, Transfer, Thr', it would be: A type of transfer RNA (tRNA) that carries the amino acid threonine (Thr) to the ribosome during protein synthesis and has an anticodon sequence complementary to one or more of the codons ACU, ACA, ACC, or ACG.

Trypsin is a proteolytic enzyme, specifically a serine protease, that is secreted by the pancreas as an inactive precursor, trypsinogen. Trypsinogen is converted into its active form, trypsin, in the small intestine by enterokinase, which is produced by the intestinal mucosa.

Trypsin plays a crucial role in digestion by cleaving proteins into smaller peptides at specific arginine and lysine residues. This enzyme helps to break down dietary proteins into amino acids, allowing for their absorption and utilization by the body. Additionally, trypsin can activate other zymogenic pancreatic enzymes, such as chymotrypsinogen and procarboxypeptidases, thereby contributing to overall protein digestion.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

RNA Polymerase II is a type of enzyme responsible for transcribing DNA into RNA in eukaryotic cells. It plays a crucial role in the process of gene expression, where the information stored in DNA is used to create proteins. Specifically, RNA Polymerase II transcribes protein-coding genes to produce precursor messenger RNA (pre-mRNA), which is then processed into mature mRNA. This mature mRNA serves as a template for protein synthesis during translation.

RNA Polymerase II has a complex structure, consisting of multiple subunits, and it requires the assistance of various transcription factors and coactivators to initiate and regulate transcription. The enzyme recognizes specific promoter sequences in DNA, unwinds the double-stranded DNA, and synthesizes a complementary RNA strand using one of the unwound DNA strands as a template. This process results in the formation of a nascent RNA molecule that is further processed into mature mRNA for protein synthesis or other functional RNAs involved in gene regulation.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Transcription factors are proteins that play a crucial role in regulating gene expression by controlling the transcription of DNA to messenger RNA (mRNA). When referring to "General Transcription Factors," it indicates a specific group of these proteins that are involved in the basal transcription machinery, which is necessary for the transcription of protein-coding genes in all organisms. These general transcription factors are required for the initiation of transcription and include several conserved components:

1. TFIIA (Transcription Factor II A) - a heterotrimeric complex that binds to the TATA box region of the promoter, enhancing the stability and specificity of the pre-initiation complex.
2. TFIID (Transcription Factor II D) - a multi-subunit complex containing the TATA-binding protein (TBP) and several TBP-associated factors (TAFs). TBP recognizes and binds to the TATA box, while TAFs contribute to promoter recognition, chromatin remodeling, and transcription activation.
3. TFIIB - a single polypeptide that interacts with both TFIID and RNA polymerase II, helping to position the polymerase correctly at the transcription start site.
4. TFIIF - a heterotrimeric complex that stabilizes the interaction between TFIIB and RNA polymerase II, promoting the formation of the pre-initiation complex.
5. TFIIE - a heterodimeric complex that interacts with TFIIB, TFIIF, and RNA polymerase II, playing a role in promoter clearance and the transition from initiation to elongation.
6. TFIIH - a multi-subunit complex containing helicase and kinase activities. It is involved in promoter opening, DNA melting at the transcription start site, and phosphorylation of the C-terminal domain (CTD) of RNA polymerase II to facilitate elongation.

These general transcription factors work together to form a pre-initiation complex that enables RNA polymerase II to initiate transcription accurately and efficiently.

Bacterial RNA refers to the genetic material present in bacteria that is composed of ribonucleic acid (RNA). Unlike higher organisms, bacteria contain a single circular chromosome made up of DNA, along with smaller circular pieces of DNA called plasmids. These bacterial genetic materials contain the information necessary for the growth and reproduction of the organism.

Bacterial RNA can be divided into three main categories: messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA). mRNA carries genetic information copied from DNA, which is then translated into proteins by the rRNA and tRNA molecules. rRNA is a structural component of the ribosome, where protein synthesis occurs, while tRNA acts as an adapter that brings amino acids to the ribosome during protein synthesis.

Bacterial RNA plays a crucial role in various cellular processes, including gene expression, protein synthesis, and regulation of metabolic pathways. Understanding the structure and function of bacterial RNA is essential for developing new antibiotics and other therapeutic strategies to combat bacterial infections.

Nucleic acid conformation refers to the three-dimensional structure that nucleic acids (DNA and RNA) adopt as a result of the bonding patterns between the atoms within the molecule. The primary structure of nucleic acids is determined by the sequence of nucleotides, while the conformation is influenced by factors such as the sugar-phosphate backbone, base stacking, and hydrogen bonding.

Two common conformations of DNA are the B-form and the A-form. The B-form is a right-handed helix with a diameter of about 20 Å and a pitch of 34 Å, while the A-form has a smaller diameter (about 18 Å) and a shorter pitch (about 25 Å). RNA typically adopts an A-form conformation.

The conformation of nucleic acids can have significant implications for their function, as it can affect their ability to interact with other molecules such as proteins or drugs. Understanding the conformational properties of nucleic acids is therefore an important area of research in molecular biology and medicine.

I believe there may be a slight error in the term you're asking about. "Asp" doesn't specifically relate to RNA (Ribonucleic Acid) or its types. However, I can provide a definition for "Transfer RNA" (tRNA).

Transfer RNA (tRNA) is a type of RNA that plays a crucial role in protein synthesis. It carries and transfers specific amino acids to the growing polypeptide chain during translation, according to the genetic code provided by messenger RNA (mRNA). Each tRNA molecule has an anticodon region which can base-pair with a complementary codon in the mRNA, and a corresponding amino acid attached to its other end. This enables the correct matching of amino acids to form proteins according to the genetic information encoded in mRNA.

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

Fusidic Acid is a steroid antibiotic, derived from the fungus Fusidium coccineum. It is primarily used to treat skin infections and other susceptible bacterial infections. It works by inhibiting bacterial protein synthesis. In medical terms, it can be defined as:

A triterpenoid antibiotic derived from the fungus Fusidium coccineum, used primarily to treat staphylococcal and streptococcal skin infections that are resistant to other antibiotics. It inhibits bacterial protein synthesis by binding to the bacterial elongation factor EF-G, preventing translocation of peptidyl tRNA from the A site to the P site on the ribosome.

It is important to note that resistance to fusidic acid can develop and its use should be reserved for infections caused by organisms known to be susceptible to it. It is not typically used as a first-line antibiotic, but rather as a secondary option when other treatments have failed or are contraindicated.

Guanosine tetraphosphate, also known as P1,P3-cyclic di-GMP or cdG, is a second messenger molecule that plays a role in the regulation of various cellular processes in bacteria and some plants. It is a cyclic compound consisting of two guanosine monophosphate (GMP) units linked by two phosphate groups.

This molecule is involved in the regulation of diverse bacterial functions, such as biofilm formation, motility, virulence, and stress response. The intracellular levels of c-di-GMP are controlled through the activity of enzymes called diguanylate cyclases (DGCs) and phosphodiesterases (PDEs). DGCs synthesize c-di-GMP from two GTP molecules, while PDEs degrade it into linear forms.

While guanosine tetraphosphate is not a common term in human or animal medicine, understanding its role in bacterial signaling and regulation can contribute to the development of novel strategies for controlling bacterial infections and other related applications.

A codon is a sequence of three adjacent nucleotides in DNA or RNA that specifies the insertion of a particular amino acid during protein synthesis, or signals the beginning or end of translation. In DNA, these triplets are read during transcription to produce a complementary mRNA molecule, which is then translated into a polypeptide chain during translation. There are 64 possible codons in the standard genetic code, with 61 encoding for specific amino acids and three serving as stop codons that signal the termination of protein synthesis.

Aminoacyl-tRNA synthetases (also known as aminoacyl-tRNA ligases) are a group of enzymes that play a crucial role in protein synthesis. They are responsible for attaching specific amino acids to their corresponding transfer RNAs (tRNAs), creating aminoacyl-tRNA complexes. These complexes are then used in the translation process to construct proteins according to the genetic code.

Each aminoacyl-tRNA synthetase is specific to a particular amino acid, and there are 20 different synthetases in total, one for each of the standard amino acids. The enzymes catalyze the reaction between an amino acid and ATP to form an aminoacyl-AMP intermediate, which then reacts with the appropriate tRNA to create the aminoacyl-tRNA complex. This two-step process ensures the fidelity of the translation process by preventing mismatching of amino acids with their corresponding tRNAs.

Defects in aminoacyl-tRNA synthetases can lead to various genetic disorders and diseases, such as Charcot-Marie-Tooth disease type 2D, distal spinal muscular atrophy, and leukoencephalopathy with brainstem and spinal cord involvement and lactate acidosis (LBSL).

Electrophoresis, polyacrylamide gel (EPG) is a laboratory technique used to separate and analyze complex mixtures of proteins or nucleic acids (DNA or RNA) based on their size and electrical charge. This technique utilizes a matrix made of cross-linked polyacrylamide, a type of gel, which provides a stable and uniform environment for the separation of molecules.

In this process:

1. The polyacrylamide gel is prepared by mixing acrylamide monomers with a cross-linking agent (bis-acrylamide) and a catalyst (ammonium persulfate) in the presence of a buffer solution.
2. The gel is then poured into a mold and allowed to polymerize, forming a solid matrix with uniform pore sizes that depend on the concentration of acrylamide used. Higher concentrations result in smaller pores, providing better resolution for separating smaller molecules.
3. Once the gel has set, it is placed in an electrophoresis apparatus containing a buffer solution. Samples containing the mixture of proteins or nucleic acids are loaded into wells on the top of the gel.
4. An electric field is applied across the gel, causing the negatively charged molecules to migrate towards the positive electrode (anode) while positively charged molecules move toward the negative electrode (cathode). The rate of migration depends on the size, charge, and shape of the molecules.
5. Smaller molecules move faster through the gel matrix and will migrate farther from the origin compared to larger molecules, resulting in separation based on size. Proteins and nucleic acids can be selectively stained after electrophoresis to visualize the separated bands.

EPG is widely used in various research fields, including molecular biology, genetics, proteomics, and forensic science, for applications such as protein characterization, DNA fragment analysis, cloning, mutation detection, and quality control of nucleic acid or protein samples.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

Aminoglycosides are a class of antibiotics that are derived from bacteria and are used to treat various types of infections caused by gram-negative and some gram-positive bacteria. These antibiotics work by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death.

Some examples of aminoglycosides include gentamicin, tobramycin, neomycin, and streptomycin. These antibiotics are often used in combination with other antibiotics to treat severe infections, such as sepsis, pneumonia, and urinary tract infections.

Aminoglycosides can have serious side effects, including kidney damage and hearing loss, so they are typically reserved for use in serious infections that cannot be treated with other antibiotics. They are also used topically to treat skin infections and prevent wound infections after surgery.

It's important to note that aminoglycosides should only be used under the supervision of a healthcare professional, as improper use can lead to antibiotic resistance and further health complications.

"Geobacillus stearothermophilus" is a species of gram-positive, rod-shaped bacteria that is thermophilic, meaning it thrives at relatively high temperatures. It is commonly found in soil and hot springs, and can also be found in other environments such as compost piles, oil fields, and even in some food products.

The bacterium is known for its ability to form endospores that are highly resistant to heat, radiation, and chemicals, making it a useful organism for sterility testing and bioprotection applications. It has an optimum growth temperature of around 60-70°C (140-158°F) and can survive at temperatures up to 80°C (176°F).

In the medical field, "Geobacillus stearothermophilus" is not typically associated with human disease or infection. However, there have been rare cases of infections reported in immunocompromised individuals who have come into contact with contaminated medical devices or materials.

Sequence homology, amino acid, refers to the similarity in the order of amino acids in a protein or a portion of a protein between two or more species. This similarity can be used to infer evolutionary relationships and functional similarities between proteins. The higher the degree of sequence homology, the more likely it is that the proteins are related and have similar functions. Sequence homology can be determined through various methods such as pairwise alignment or multiple sequence alignment, which compare the sequences and calculate a score based on the number and type of matching amino acids.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Macromolecular substances, also known as macromolecules, are large, complex molecules made up of repeating subunits called monomers. These substances are formed through polymerization, a process in which many small molecules combine to form a larger one. Macromolecular substances can be naturally occurring, such as proteins, DNA, and carbohydrates, or synthetic, such as plastics and synthetic fibers.

In the context of medicine, macromolecular substances are often used in the development of drugs and medical devices. For example, some drugs are designed to bind to specific macromolecules in the body, such as proteins or DNA, in order to alter their function and produce a therapeutic effect. Additionally, macromolecular substances may be used in the creation of medical implants, such as artificial joints and heart valves, due to their strength and durability.

It is important for healthcare professionals to have an understanding of macromolecular substances and how they function in the body, as this knowledge can inform the development and use of medical treatments.

Guanylyl Imidodiphosphate (GIP) is not a medical term itself, but it is a biochemical compound that plays a crucial role in the body's signaling pathways. It is a vital intracellular second messenger involved in various physiological processes, including vasodilation and smooth muscle relaxation.

To be more specific, GIP is a nucleotide that activates a family of enzymes called guanylyl cyclases (GCs). Once activated, these enzymes convert guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), another essential second messenger. The increased levels of cGMP then mediate the relaxation of smooth muscle and vasodilation by activating protein kinases and ion channels, among other mechanisms.

In summary, Guanylyl Imidodiphosphate (GIP) is a biochemical compound that plays a critical role in intracellular signaling pathways, leading to vasodilation and smooth muscle relaxation.

"Saccharomyces cerevisiae" is not typically considered a medical term, but it is a scientific name used in the field of microbiology. It refers to a species of yeast that is commonly used in various industrial processes, such as baking and brewing. It's also widely used in scientific research due to its genetic tractability and eukaryotic cellular organization.

However, it does have some relevance to medical fields like medicine and nutrition. For example, certain strains of S. cerevisiae are used as probiotics, which can provide health benefits when consumed. They may help support gut health, enhance the immune system, and even assist in the digestion of certain nutrients.

In summary, "Saccharomyces cerevisiae" is a species of yeast with various industrial and potential medical applications.

A peptide library is a collection of a large number of peptides, which are short chains of amino acids. Each peptide in the library is typically composed of a defined length and sequence, and may contain a variety of different amino acids. Peptide libraries can be synthesized using automated techniques and are often used in scientific research to identify potential ligands (molecules that bind to specific targets) or to study the interactions between peptides and other molecules.

In a peptide library, each peptide is usually attached to a solid support, such as a resin bead, and the entire library can be created using split-and-pool synthesis techniques. This allows for the rapid and efficient synthesis of a large number of unique peptides, which can then be screened for specific activities or properties.

Peptide libraries are used in various fields such as drug discovery, proteomics, and molecular biology to identify potential therapeutic targets, understand protein-protein interactions, and develop new diagnostic tools.

Genetic transcription is the process by which the information in a strand of DNA is used to create a complementary RNA molecule. This process is the first step in gene expression, where the genetic code in DNA is converted into a form that can be used to produce proteins or functional RNAs.

During transcription, an enzyme called RNA polymerase binds to the DNA template strand and reads the sequence of nucleotide bases. As it moves along the template, it adds complementary RNA nucleotides to the growing RNA chain, creating a single-stranded RNA molecule that is complementary to the DNA template strand. Once transcription is complete, the RNA molecule may undergo further processing before it can be translated into protein or perform its functional role in the cell.

Transcription can be either "constitutive" or "regulated." Constitutive transcription occurs at a relatively constant rate and produces essential proteins that are required for basic cellular functions. Regulated transcription, on the other hand, is subject to control by various intracellular and extracellular signals, allowing cells to respond to changing environmental conditions or developmental cues.

Tertiary protein structure refers to the three-dimensional arrangement of all the elements (polypeptide chains) of a single protein molecule. It is the highest level of structural organization and results from interactions between various side chains (R groups) of the amino acids that make up the protein. These interactions, which include hydrogen bonds, ionic bonds, van der Waals forces, and disulfide bridges, give the protein its unique shape and stability, which in turn determines its function. The tertiary structure of a protein can be stabilized by various factors such as temperature, pH, and the presence of certain ions. Any changes in these factors can lead to denaturation, where the protein loses its tertiary structure and thus its function.

Transfer RNA (tRNA) is a type of RNA molecule that plays a crucial role in protein synthesis, the process by which cells create proteins. During protein synthesis, tRNAs serve as adaptors, translating the genetic code present in messenger RNA (mRNA) into the corresponding amino acids required to build a protein.

Each tRNA molecule has an anticodon region that can base-pair with specific codons (three-nucleotide sequences) on the mRNA. At the other end of the tRNA is the acceptor stem, which contains a binding site for the corresponding amino acid. When an amino acid attaches to the tRNA, it forms an ester bond between the carboxyl group of the amino acid and the 3'-hydroxyl group of the ribose in the tRNA. This aminoacylated tRNA then participates in the translation process, delivering the amino acid to the growing polypeptide chain at the ribosome.

In summary, transfer RNA (tRNA) is a type of RNA molecule that facilitates protein synthesis by transporting and delivering specific amino acids to the ribosome for incorporation into a polypeptide chain, based on the codon-anticodon pairing between tRNAs and messenger RNA (mRNA).

Amino acids are organic compounds that serve as the building blocks of proteins. They consist of a central carbon atom, also known as the alpha carbon, which is bonded to an amino group (-NH2), a carboxyl group (-COOH), a hydrogen atom (H), and a variable side chain (R group). The R group can be composed of various combinations of atoms such as hydrogen, oxygen, sulfur, nitrogen, and carbon, which determine the unique properties of each amino acid.

There are 20 standard amino acids that are encoded by the genetic code and incorporated into proteins during translation. These include:

1. Alanine (Ala)
2. Arginine (Arg)
3. Asparagine (Asn)
4. Aspartic acid (Asp)
5. Cysteine (Cys)
6. Glutamine (Gln)
7. Glutamic acid (Glu)
8. Glycine (Gly)
9. Histidine (His)
10. Isoleucine (Ile)
11. Leucine (Leu)
12. Lysine (Lys)
13. Methionine (Met)
14. Phenylalanine (Phe)
15. Proline (Pro)
16. Serine (Ser)
17. Threonine (Thr)
18. Tryptophan (Trp)
19. Tyrosine (Tyr)
20. Valine (Val)

Additionally, there are several non-standard or modified amino acids that can be incorporated into proteins through post-translational modifications, such as hydroxylation, methylation, and phosphorylation. These modifications expand the functional diversity of proteins and play crucial roles in various cellular processes.

Amino acids are essential for numerous biological functions, including protein synthesis, enzyme catalysis, neurotransmitter production, energy metabolism, and immune response regulation. Some amino acids can be synthesized by the human body (non-essential), while others must be obtained through dietary sources (essential).

Histidine is an essential amino acid, meaning it cannot be synthesized by the human body and must be obtained through dietary sources. Its chemical formula is C6H9N3O2. Histidine plays a crucial role in several physiological processes, including:

1. Protein synthesis: As an essential amino acid, histidine is required for the production of proteins, which are vital components of various tissues and organs in the body.

2. Hemoglobin synthesis: Histidine is a key component of hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. The imidazole side chain of histidine acts as a proton acceptor/donor, facilitating the release and uptake of oxygen by hemoglobin.

3. Acid-base balance: Histidine is involved in maintaining acid-base homeostasis through its role in the biosynthesis of histamine, which is a critical mediator of inflammatory responses and allergies. The decarboxylation of histidine results in the formation of histamine, which can increase vascular permeability and modulate immune responses.

4. Metal ion binding: Histidine has a high affinity for metal ions such as zinc, copper, and iron. This property allows histidine to participate in various enzymatic reactions and maintain the structural integrity of proteins.

5. Antioxidant defense: Histidine-containing dipeptides, like carnosine and anserine, have been shown to exhibit antioxidant properties by scavenging reactive oxygen species (ROS) and chelating metal ions. These compounds may contribute to the protection of proteins and DNA from oxidative damage.

Dietary sources of histidine include meat, poultry, fish, dairy products, and wheat germ. Histidine deficiency is rare but can lead to growth retardation, anemia, and impaired immune function.

Recombinant proteins are artificially created proteins produced through the use of recombinant DNA technology. This process involves combining DNA molecules from different sources to create a new set of genes that encode for a specific protein. The resulting recombinant protein can then be expressed, purified, and used for various applications in research, medicine, and industry.

Recombinant proteins are widely used in biomedical research to study protein function, structure, and interactions. They are also used in the development of diagnostic tests, vaccines, and therapeutic drugs. For example, recombinant insulin is a common treatment for diabetes, while recombinant human growth hormone is used to treat growth disorders.

The production of recombinant proteins typically involves the use of host cells, such as bacteria, yeast, or mammalian cells, which are engineered to express the desired protein. The host cells are transformed with a plasmid vector containing the gene of interest, along with regulatory elements that control its expression. Once the host cells are cultured and the protein is expressed, it can be purified using various chromatography techniques.

Overall, recombinant proteins have revolutionized many areas of biology and medicine, enabling researchers to study and manipulate proteins in ways that were previously impossible.

Elongation+Factor+G at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Peptide+Elongation+Factor+Tu at ... Most common elongation factors in prokaryotes are EF-Tu, EF-Ts, EF-G. Bacteria and eukaryotes use elongation factors that are ... ISBN 81-7663-109-4.[page needed] nobelprize.org Explaining the function of eukaryotic elongation factors Elongation+Factor at ... In bacteria, selenocysteinyl-tRNA requires a special elongation factor SelB (P14081) related to EF-Tu. A few homologs are also ...
... peptide elongation factor g MeSH D08.811.277.040.330.300.100.700 - peptide elongation factor tu MeSH D08.811.277.040.330.300. ... 100.800 - peptide elongation factor 1 MeSH D08.811.277.040.330.300.100.850 - peptide elongation factor 2 MeSH D08.811.277.040. ... factor viia MeSH D08.811.277.656.300.760.310 - factor ixa MeSH D08.811.277.656.300.760.315 - factor xa MeSH D08.811.277.656. ... complement factor b MeSH D08.811.277.656.300.760.200 - complement factor d MeSH D08.811.277.656.300.760.210 - complement factor ...
Peptide+Elongation+Factor+Tu at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the ... Prokaryotic elongation factors EF-Ts (elongation factor thermo stable) EF-G (elongation factor G) EF-P (elongation factor P) ... EF-Tu (elongation factor thermo unstable) is a prokaryotic elongation factor responsible for catalyzing the binding of an ... In the cytoplasm, the deactivated EF-Tu • GDP is acted on by the prokaryotic elongation factor EF-Ts, which causes EF-Tu to ...
... peptide chain release factor 2, 16S rRNA (cytosine(1402)-N(4))-methyltransferase, elongation factor Tu, UDP-N-acetylglucosamine ...
Factor T is one of two complementary factors that are required for the elongation of peptide bonds on ribosomes within E. coli ... Factor T divides into Tu and Ts components, where in the presence of GTP, a Tu-Ts complex will dissociated to Tu and Ts, and ... and many other prokaryotic elongation factors. Kaziro then explains how GTP interacts with these prokaryotic elongation factors ... Kaziro then overviews prominent complementary factors involved with protein elongation such as EF-Tu, EF-Ts, ...
EF-Tu, EF-Ts, and EF-G. EF-P was discovered in 1975 by Glick and Ganoza, as a factor that increased the yield of peptide bond ... Prokaryotic elongation factors EF-Ts (elongation factor thermo stable) EF-Tu (elongation factor thermo unstable) EF-G ( ... initiation factors, elongation factors and termination factors. The elongation phase of translation is promoted by three ... EF-P (elongation factor P) is an essential protein that in bacteria stimulates the formation of the first peptide bonds in ...
... elongation factor Tu, the RNA polymerase beta-subunit, and the ribosomal proteins L2, S5, and S11. Where "Ca. K. muelleri" is ... The tree was constructed by comparing the peptide sequences of ten different types of proteins. The proteins used were the DNA ... polymerase III beta-subunit, initiation factor IF-2, leucyl-tRNA synthetase, the phenylalanine-tRNA ligase beta-subunit, VARS, ...
... s (EC 3.6.5.3, elongation factor (EF), initiation factor (IF), peptide-release or termination factor ... They usually include translation initiation factors such as IF-2 and translation elongation factors such as EF-Tu. Kurzchalia ... Rodnina MV, Savelsbergh A, Katunin VI, Wintermeyer W (January 1997). "Hydrolysis of GTP by elongation factor G drives tRNA ... "Release factor RF3 in E.coli accelerates the dissociation of release factors RF1 and RF2 from the ribosome in a GTP-dependent ...
"Ribosomally synthesized thiopeptide antibiotics targeting elongation factor Tu". J. Am. Chem. Soc. 131 (16): 5946-55. doi: ... The precursor of thiostrepton contains 58 amino acids in the peptide chain, which includes 41-aa leader peptide (LP) and 17-aa ... Bycroft, Barrie W.; Gowland, Maxim S. (1978). "The structures of the highly modified peptide antibiotics micrococcin P1 and P2 ... Thiostrepton is a natural product of the ribosomally synthesized and post-translationally modified peptide (RiPP) class. ...
... peptide elongation factor g MeSH D12.776.835.700.350.700 - peptide elongation factor tu MeSH D12.776.835.700.350.800 - peptide ... elongation factor 1 MeSH D12.776.835.700.350.850 - peptide elongation factor 2 MeSH D12.776.835.725.868.124 - eukaryotic ... vascular endothelial growth factor a MeSH D12.776.467.100.800.300 - vascular endothelial growth factor b MeSH D12.776.467.100. ... fibroblast growth factor 4 MeSH D12.776.624.664.700.112 - fibroblast growth factor 6 MeSH D12.776.624.664.700.114 - fms-like ...
... peptide elongation factor g MeSH D12.776.157.325.150.700 - peptide elongation factor tu MeSH D12.776.157.325.150.800 - peptide ... elongation factor 1 MeSH D12.776.157.325.150.850 - peptide elongation factor 2 MeSH D12.776.157.325.332.100 - gtp-binding ... MeSH D12.776.157.057.030.124 - interferon regulatory factor-1 MeSH D12.776.157.057.030.249 - interferon regulatory factor-2 ... adp-ribosylation factors MeSH D12.776.157.325.515.100.100 - adp-ribosylation factor 1 MeSH D12.776.157.325.515.400 - rab gtp- ...
This binding is facilitated by elongation factor-Tu (EF-Tu), a small GTPase. For fast and accurate recognition of the ... And the E site which is the exit site of the now uncharged tRNA after it gives its amino acid to the growing peptide chain. The ... Prokaryotic initiation factors Prokaryotic elongation factors Farabaugh PJ (August 1978). "Sequence of the lacI gene". Nature. ... Once the nascent protein is released in termination, Ribosome Recycling Factor and Elongation Factor G (EF-G) function to ...
... peptide - peptide bond - peptide elongation factor - peptide elongation factor tu - peptide fragment - peptide initiation ... transforming growth factor - transforming growth factor alpha - transforming growth factor beta - transforming growth factor ... factor - peptide receptor - peptide termination factor - peripheral membrane protein - pesticide - pH - phage display - ... sigma factor - signal peptide - signal recognition particle - signal sequence - signal transduction - sincalide - skeleton - ...
"NMR study of the phosphate-binding elements of Escherichia coli elongation factor Tu catalytic domain". Biochemistry. 30 (45): ... Ivanov, D.; Bachovchin, W.W.; Redfield, Alfred G. (2002). "Boron-11 pure quadrupole resonance investigation of peptide boronic ... "NMR study of the phosphate-binding loops of Thermus thermophilus elongation factor Tu". Biochemistry. 31 (11): 2977-2982. doi: ...
During translation elongation, tRNA first binds to the ribosome as part of a complex with elongation factor Tu (EF-Tu) or its ... Once the peptide bond is formed, the tRNA in the P/P site is acylated, or has a free 3' end, and the tRNA in the A/A site ... These are the T site (named elongation factor Tu) and I site (initiation). By convention, the tRNA binding sites are denoted ... and elongation factors EF-G and EF-Tu". Quarterly Reviews of Biophysics. 42 (3): 159-200. doi:10.1017/S0033583509990060. PMC ...
Bacterial release factors include RF1, RF2, and RF3 (or PrfA, PrfB, PrfC in the "peptide release factor" gene nomenclature). ... November 2010). "Omnipotent role of archaeal elongation factor 1 alpha (EF1α in translational elongation and termination, and ... The triggering mechanism is similar to that of aa-tRNA-EF-Tu-GTP. A homologous system is Dom34/Pelota-Hbs1, a eukaryotic system ... Class 2 release factors are GTPases that enhance the activity of class 1 release factors. It helps the class 1 RF dissociate ...
Rao TR, Slobin LI (Mar 1986). "Structure of the amino-terminal end of mammalian elongation factor Tu". Nucleic Acids Research. ... "Protein kinase C delta-specific phosphorylation of the elongation factor eEF-alpha and an eEF-1 alpha peptide at threonine 431 ... an elongation factor protein, a GTPase, and an actin bundling protein. As an elongation factor, it is known to mediate the ... Elongation factor 1-alpha 1 (eEF1a1) is a translation elongation protein, expressed across eukaryotes. In humans, it is encoded ...
"GTP-binding membrane protein of Escherichia coli with sequence homology to initiation factor 2 and elongation factors Tu and G ... Additionally, LepA has an effect on peptide bond formation. Through various studies in which functional derivatives of ... Elongation factor 4 (EF-4) is an elongation factor that is thought to back-translocate on the ribosome during the translation ... Prokaryotic elongation factors Eukaryotic elongation factors Margus, Tõnu; Remm, Maido; Tenson, Tanel (December 2007). " ...
Prokaryotic elongation factors EF-Ts (elongation factor thermo stable) EF-Tu (elongation factor thermo unstable) EF-P ( ... doi:10.1038/s41467-021-27415-0. Peptide+Elongation+Factor+G at the U.S. National Library of Medicine Medical Subject Headings ( ... like Initiation Factor 2, Elongation factor-Tu, Release Factor 3, and EF-G. Specifically, the C-terminal of L7/L12 will bind to ... EF-G (elongation factor G, historically known as translocase) is a prokaryotic elongation factor involved in protein ...
1996). "Interaction of mitochondrial elongation factors Tu.Ts with aminoacyl-tRNA". Nucleic Acids Symp. Ser. (33): 163-6. PMID ... Maksimov VV, Arman IP, Tarantul VZ (2006). "[Identification of the proteins interacting with neuroprotective peptide humanin in ... Elongation factor Ts, mitochondrial is a protein that in humans is encoded by the TSFM gene. It is an EF-Ts homolog. GRCh38: ... Vernon JL, Burr PC, Wiley JE, Farwell MA (2000). "Assignment of the mitochondrial translation elongation factor Ts gene (TSFM) ...
Finally, the resulting Sec-tRNASec is specifically bound to an alternative translational elongation factor (SelB or mSelB (or ... Merck Index, 12th Edition, 8584 "Nomenclature and Symbolism for Amino Acids and Peptides". IUPAC-IUB Joint Commission on ... EF-Tu in bacteria, eEF1A in eukaryotes).[Archaea?] Rather, the tRNA-bound seryl residue is converted to a selenocysteine ... the resulting Ser-tRNASec is not used for translation because it is not recognised by the normal translation elongation factor ...
Elongation factor Tu, mitochondrial is a protein that in humans is encoded by the TUFM gene. It is an EF-Tu homolog. GRCh38: ... "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides". Nat. ... Ling M, Merante F, Chen HS, Duff C, Duncan AM, Robinson BH (Nov 1997). "The human mitochondrial elongation factor tu (EF-Tu) ... "Entrez Gene: TUFM Tu translation elongation factor, mitochondrial". Wells J, Henkler F, Leversha M, Koshy R (1995). "A ...
Incoming amino acid monomers enter the ribosomal A site in the form of aminoacyl-tRNAs complexed with elongation factor Tu (EF- ... While the crucial activities of decoding and peptide transfer are RNA based, proteins play an active role in functions that may ... is translocated to the P site with the aid the elongation factor G (EF-G) and GTP as the deacylated tRNA is released from the ... Tu) and GTP. The growing polypeptide chain, situated in the P site as peptidyl-tRNA, is then transferred to aminoacyl-tRNA and ...
The elongation factor EF-Tu has been shown to stabilize the bond by preventing weak acyl linkages from being hydrolyzed. All ... Alone, an amino acid is not the substrate necessary to allow for the formation of peptide bonds within a growing polypeptide ... along with particular elongation factors, deliver the amino acid to the ribosome for incorporation into the polypeptide chain ... Research into the stability of aa-tRNAs illustrates that the acyl (or ester) linkage is the most important conferring factor, ...
The tmRNA forms a ribonucleoprotein complex (tmRNP) together with Small Protein B (SmpB), Elongation Factor Tu (EF-Tu), and ... for the tag peptide, marked by the resume codon and the stop codon. The encoded tag peptide (ANDENYALAA in E. coli) varies ... Tu GF, Reid GE, Zhang JG, Moritz RL, Simpson RJ (April 1995). "C-terminal extension of truncated recombinant proteins in ... Depending on the organism, the tag peptide may be recognized by a variety of proteases or protease adapters. ssrA is both a ...
"Stop codon recognition and interactions with peptide release factor RF3 of truncated and chimeric RF1 and RF2 from Escherichia ... Elongation: The last tRNA validated by the small ribosomal subunit (accommodation) transfers the amino acid. It carries to the ... In bacteria, this aminoacyl-tRNA is carried to the ribosome by EF-Tu, where mRNA codons are matched through complementary base ... Then, a peptide bond forms between the amino acid of the tRNA in the A site and the amino acid of the charged tRNA in the P/E ...
... are two eukaryotic elongation factors. It forms two complexes, the EF-Tu homolog EF-1A and the EF-Ts homolog EF-1B, the ... Peptide+Elongation+Factor+1 at the U.S. National Library of Medicine Medical Subject Headings (MeSH) (Protein pages needing a ... November 2010). "Omnipotent role of archaeal elongation factor 1 alpha (EF1α in translational elongation and termination, and ... Sasikumar AN, Perez WB, Kinzy TG (2011). "The many roles of the eukaryotic elongation factor 1 complex". Wiley ...
Translation Elongation Factors and Histones". PLOS Genetics. 12 (5): e1006023. doi:10.1371/journal.pgen.1006023. PMC 4854385. ... Truttmann MC, Cruz VE, Guo X, Engert C, Schwartz TU, Ploegh HL (May 2016). "The Caenorhabditis elegans Protein FIC-1 Is an ... Due to AMP's stability, peptide fragmentation spectra is easy to read manually or with search engines. Inhibitors of protein ... This extra-ER pool of FICD-1s is credited with AMPylation of core histones and eEF1-A type translation factors within the ...
... elongation factor Tu, mitochondrial (EFTU), glyceraldehyde-3-phosphate dehydrogenase (G3P), stress-70 protein, mitochondrial ( ... Peptide mass fingerprinting identifies a protein by cleaving it into short peptides and then deduces the protein's identity by ... There are different factors that can add variability to proteins. SAPs (single amino acid polymorphisms) and non-synonymous ... Tandem mass spectrometry, on the other hand, can get sequence information from individual peptides by isolating them, colliding ...
"Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation". Proc. Natl. Acad. Sci. U.S.A. ... by substrate analog peptides". Bioorg. Med. Chem. Lett. 21 (14): 4325-4328. doi:10.1016/j.bmcl.2011.05.050. PMID 21665470. ... Flashman E, Davies SL, Yeoh KK, Schofield CJ (March 2010). "Investigating the dependence of the hypoxia-inducible factor ... and factor inhibiting HIF (FIH)". J. Inorg. Biochem. 113: 25-30. doi:10.1016/j.jinorgbio.2012.03.002. PMC 3525482. PMID ...
  • The small fraction of hmtRNAMet that can be aminoacylated is not formylated by the mitochondrial Met-tRNA transformylase preventing its function in initiation, and it is unable to form a stable ternary complex with elongation factor EF-Tu preventing any participation in chain elongation. (ncsu.edu)
  • One is used solely for initiation, and the other functions in polypeptide chain elongation. (ncsu.edu)
  • Animal mitochondria are quite unusual in that they contain a single gene for tRNAMet, which functions in both polypeptide chain initiation and chain elongation. (ncsu.edu)
  • The role of this modification in (hmtRNAMetCAU) for the decoding of AUA, as well as AUG, in both the peptidyl- and aminoacyl-sites of the ribosome in either chain initiation or chain elongation is still unknown. (ncsu.edu)
  • Factors that utilize energy from the hydrolysis of GTP to GDP for peptide chain elongation. (childrensmercy.org)
  • Following initiation-factor mediated assembly of the 70S IC, the first aminoacyl-tRNA is delivered to the ribosome in ternary complex with elongation factor Tu (EF-Tu) and GTP. (columbia.edu)
  • Eukaryotic elongation factor 1 alpha (eEF1A) is one of the four subunits composing eukaryotic translation elongation factor 1. (biomedcentral.com)
  • The eukaryotic translation elongation factor 1 alpha, currently termed eEF1A, is a member of the G protein family, and one of the four subunits that compose the eukaryotic elongation factor 1 [ 5 , 6 ]. (biomedcentral.com)
  • The 50S subunit joining reaction is catalyzed by GTP-bound IF2 and results in formation of a 70S initiation complex (70S IC) that contains an initiator transfer RNA (tRNA) and is primed for formation of the first peptide bond. (columbia.edu)
  • Of special interest are the translation initiation factors eIF2, a GTPase that binds methionyl-tRNA to the ribosome, and eIF5B, a second GTPase that catalyzes ribosomal subunit joining in the final step of translation initiation. (nih.gov)
  • The first step of protein synthesis is binding of the initiator Met-tRNA to the small ribosomal subunit by the factor eIF2, which is composed of three subunits. (nih.gov)
  • The gamma subunit of eIF2 is a GTPase that resembles the bacterial translation elongation factor EF-Tu. (nih.gov)
  • Accommodation of aminoacyl-tRNA into the ribosome's peptidyl transferase center leads to formation of the first peptide bond, which signals the end of initiation and entry into the elongation phase of protein synthesis. (columbia.edu)
  • Elongation factors are a set of proteins that function at the ribosome, during protein synthesis, to facilitate translational elongation from the formation of the first to the last peptide bond of a growing polypeptide. (wikipedia.org)
  • Our method allows for the identification of the proteins, identification of redox-sensitive cysteines within proteins, and quantification of the redox status of individual cysteine-containing peptides. (hindawi.com)
  • Additional regulatory proteins are often required to induce the conformational changes that occur during this cycle: guanine nucleotide exchange factors, which catalyze release of bound GDP and promote its replacement by GTP, and GTPase-activating proteins, which accelerate GTP hydrolysis. (biomedcentral.com)
  • The superfamily of G proteins includes three main classes: Ras-like GTPases, G α subunits of heterotrimeric G proteins, and the translation elongation factors. (biomedcentral.com)
  • While the crucial activities of decoding and peptide transfer are RNA based, proteins play an active role in functions that may have evolved to streamline the process of protein synthesis. (embl.de)
  • The hmtRNAMet serves both in translational initiation and elongation in human mitochondria making this tRNA of particular interest in mitochondrial protein synthesis. (ncsu.edu)
  • Aminoacylation is an early step required for the tRNA to be used in either the elongation or initiation phase of protein synthesis and is thus of central importance for protein synthesis in mitochondria. (ncsu.edu)
  • Phosphodiester backbone cleavage by sarcin or depurination by ricin of a specific site in the SRL RNA disrupts elongation factor binding to the ribosome, arrests protein synthesis, and ultimately causes cell death. (uw.edu)
  • A Disease-causing Point Mutation in Human Mitochondrial tRNA(Met) Results in tRNA Misfolding Leading to Defects in Translational Initiation and Elongation. (ncsu.edu)
  • In addition, Met-tRNAMet must interact with elongation factor EF-Tumt and bind to the A-site of the ribosome during translational elongation. (ncsu.edu)
  • The modification contributes to the tRNA's anticodon domain structure, thermodynamic properties and its ability to bind codons AUA and AUG in translational initiation and elongation. (ncsu.edu)
  • TU and T4 treatments demonstrate that SseEF1A4 is up-regulated by THs, suggesting a role in the translational regulation of the factors involved in the dramatic changes that occurs during Senegalese sole metamorphosis. (biomedcentral.com)
  • Thus this loop provides an important part of the ribosomal binding site for translational GTPases such as EF-G and EF-Tu. (uw.edu)
  • We are also examining the role of the hypusine modification on eIF5A and the role of this factor in gene-specific translational control mechanisms. (nih.gov)
  • Based on yeast genetic studies, we identify the mitochondrial translation factor MEF2 as a mediator of atorvastatin toxicity. (prolekarniky.cz)
  • The human ortholog of MEF2 is the Elongation Factor Gene (EF-G) 2, which has previously been shown to play a specific role in mitochondrial ribosome recycling. (prolekarniky.cz)
  • Recently a mutation in a novel gene, believed to be a member of the class of mitochondrial peptide release factors, was identified in patients exhibiting symptoms of Leigh syndrome [4] . (prolekarniky.cz)
  • We used this finding in a targeted reverse-genetic approach to identify a receptor kinase essential for EF-Tu perception, which we called EFR. (uea.ac.uk)
  • These results demonstrate that EFR is the EF-Tu receptor and that plant defense responses induced by PAMPs such as EF-Tu reduce transformation by Agrobacterium. (uea.ac.uk)
  • To test this in a direct reductionist approach, we transferred the Brassicaceae-specific PRR ELONGATION FACTOR-THERMO UNSTABLE RECEPTOR (EFR), conferring recognition of the bacterial EF-Tu protein, from Arabidopsis thaliana to the legume Medicago truncatula. (jic.ac.uk)
  • Myelinating OLs originate from parenchymal precursors expressing the neuron-glia antigen 2 (NG2) chondroitin sulphate proteoglycan and the platelet derived growth factor receptor alpha (PDGFRα), commonly referred to as oligodendrocyte progenitor cells (OPCs) 4 . (nature.com)
  • The other two elongation factors, SseEF1A3 and SseEF1A4 , represent novel genes that are mainly expressed in gills and skin. (biomedcentral.com)
  • TU-treated larvae exhibited lower SseEF1A4 mRNA levels than untreated controls at both 11 and 15 days after treatment, whereas transcripts of the other four genes remained relatively unchanged. (biomedcentral.com)
  • In this thesis, I report the use of single-molecule fluorescence methods to study the role of the initiation factors and ribosome-factor interactions in regulating molecular events that occur during late stages of the translation initiation pathway. (columbia.edu)
  • Molecular modeling indicates the three-dimensional structure of the peptide spine of aggregates is essentially constituted by extended β-sheet motifs stabilized by hydrogen bonds and hydrophobic interactions. (cnr.it)
  • We use molecular-genetic and biochemical studies in yeast and human cells to dissect the structure-function properties of translation factors. (nih.gov)
  • In bacteria, selenocysteinyl-tRNA requires a special elongation factor SelB (P14081) related to EF-Tu. (wikipedia.org)
  • Functional recognition of the modified human tRNA(UUU)(Lys3) anticodon domain by HIV's nucleocapsid protein and a peptide mimic. (ncsu.edu)
  • The crystal structure of EF-Tu and G24A-tRNA-Trp bound to a cognate codon on the 70S ribosome. (expasy.org)
  • We previously showed that, despite their structural similarity, eIF2 and EF-Tu bind to tRNA in substantially different manners, and we showed that the tRNA-binding domain III of EF-Tu has acquired a new function in eIF2gamma to bind to the ribosome. (nih.gov)
  • Directed mutagenesis identifies amino acid residues involved in elongation factor Tu binding to yeast Phe-tRNAPhe. (colorado.edu)
  • It helps in the formation of peptide bonds between two amino acids. (cbsetuts.com)
  • Incoming amino acid monomers enter the ribosomal A site in the form of aminoacyl-tRNAs complexed with elongation factor Tu (EF-Tu) and GTP. (embl.de)
  • The inhibition of eIF2B impairs general translation, slowing the growth of yeast cells and, paradoxically, enhancing the translation of the GCN4 mRNA (GCN4 is a transcription factor) required for yeast cells to grow under amino-acid starvation conditions. (nih.gov)
  • In the last phase (Termination) again two factors namely RF1 and RF2 are needed to stop the synthesis of the polypeptide chain. (cbsetuts.com)
  • The protease not only releases small peptides, such as the amyloid-β peptide, which drives Alzheimer's disease pathogenesis, but also intracellular domains, which can have critical functions in nuclear signaling. (cipsm.de)
  • This matches the MIF [GeneSymbol=MIF] transcription factor binding site V$MIF1_01 (v7.4 TRANSFAC). (gsea-msigdb.org)
  • The promoter analysis yields 174 candidate motifs, including most previously known transcription-factor binding sites and 105 new motifs. (gsea-msigdb.org)
  • E2F transcription factor 5 [Sou. (gsea-msigdb.org)
  • heat shock transcription factor. (gsea-msigdb.org)
  • To study the possible regulation of SseEF1A gene expressions by thyroid hormones (THs), larvae were exposed to the goitrogen thiourea (TU). (biomedcentral.com)
  • GTP Phosphohydrolase-Linked Elongation Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (childrensmercy.org)
  • citation needed] In addition to their cytoplasmic machinery, eukaryotic mitochondria and plastids have their own translation machinery, each with their own set of bacterial-type elongation factors. (wikipedia.org)
  • Arabidopsis plants detect a variety of PAMPs including conserved domains of bacterial flagellin and of bacterial EF-Tu. (uea.ac.uk)
  • Some of bacterial ribosome-inactivating toxins evolved to mimic the mechanism employed for loading onto the ribosome by translation factors. (rcsb.org)
  • a question of key mechanistic importance in understanding how the ribosome coordinates the transition from initiation to elongation thus concerns the relative timing of ternary complex binding with respect to IF2 dissociation from the 70S IC. (columbia.edu)
  • In E. coli cells at the initiation phase three initiation factors namely IF1, IF2, and IF3 promote the formation of the initiation complex. (cbsetuts.com)
  • To answer this question we determined the crystal structure of an EVH1 domain in complex with a PPxxF peptide ligand (TPPSPF). (uw.edu)
  • Structure of the Homer EVH1 Domain-Peptide Complex Reveals a New Twist in Polyproline Recognition. (uw.edu)
  • protein_coding" "AAC73288","bamA","Escherichia coli","BamABCDE complex OM biogenesis outer membrane pore-forming assembly factor [Ensembl]. (ntu.edu.sg)
  • Both a cell-intrinsic program and environmental factors participate in the regulation of OPC architecture, proliferation and oligodendro-/myelino-genesis. (nature.com)
  • Very recently we proposed novel di- and tetra-phenylalanine peptides derivatized with gadolinium complexes as potentials supramolecular diagnostic agents for applications in MRI (Magnetic Resonance Imaging). (cnr.it)
  • Most common elongation factors in prokaryotes are EF-Tu, EF-Ts, EF-G. Bacteria and eukaryotes use elongation factors that are largely homologous to each other, but with distinct structures and different research nomenclatures. (wikipedia.org)
  • In bacteria, rapid and high-fidelity translation initiation is promoted by three canonical initiation factors: IF1, IF2, and IF3. (columbia.edu)
  • This is supported by the enhanced stability at acidic pH of not only the RNA phosphodiester bond but also of the aminoacyl-(t)RNA and peptide bonds. (biomedcentral.com)
  • Elongation factors are targets for the toxins of some pathogens. (wikipedia.org)
  • One area of research in the Correll lab is to address how translation factors (such as EF-G and EF-Tu) and toxins (sarcin and ricin) recognize a universal stem-loop structure in the 23S ribosomal RNA (rRNA) - the sarcin/ricin loop (SRL). (uw.edu)
  • Expression of the Escherichia coli tryptophanase operon depends on ribosome stalling during translation of the upstream TnaC leader peptide, a process for which interactions between the TnaC nascent chain and the ribosomal exit tunnel are critical. (cipsm.de)
  • Protein conformation is critically linked to function and often controlled by interactions with regulatory factors. (cipsm.de)
  • While work by others addressed how certain EVH1 domains recognize an FPPPP peptide, it was unknown how the other class of EVH1 domains specifically recognizes the PPxxF sequence. (uw.edu)
  • the corresponding prokaryotic factor is also designated EF1A) (16Ling J. Roy H. Qin D. Rubio M.A. Alfonzo J.D. Fredrick K. Ibba M. Proc. (ncsu.edu)
  • [11] Baram D, Yonath A. From peptide-bond formation to cotranslational folding: dynamic, regulatory and evolutionary aspects. (org.ua)
  • The structural basis of ribosome activity in peptide bond synthesis. (org.ua)
  • For instance, Corynebacterium diphtheriae produces diphtheria toxin, which alters protein function in the host by inactivating elongation factor (EF-2). (wikipedia.org)
  • citation needed] Elongation factors play a role in orchestrating the events of this process, and in ensuring the high accuracy translation at these speeds. (wikipedia.org)
  • the nominal release factor MTRFR may also play a role in elongation. (wikipedia.org)
  • Phosphorylation of eIF2alpha converts eIF2 from a substrate to an inhibitor of its guanine-nucleotide exchange factor eIF2B. (nih.gov)
  • During the elongation phase three more factors namely EF Tu, EF Ts, and EF G are involved. (cbsetuts.com)
  • Various protein factors regulate the process of translation. (cbsetuts.com)